Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
12/2001
12/18/2001US6331563 N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl, Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase inhibitors
12/18/2001US6331553 Inhibitors of nitric oxide synthase; treating cerebrovascular diseases
12/18/2001US6331507 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
12/13/2001WO2001094357A1 Antitumoral compounds
12/13/2001WO2001094322A1 4-benzyl-2-hydroxy-1,4-oxazin-3-one and polymorphic forms thereof
12/13/2001WO2001094321A1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists
12/13/2001WO2001044200A3 Selective neurokinin antagonists
12/13/2001US20010051722 Aminoaryl Oxazolidinone N-oxides
12/13/2001US20010051621 Mixing Linezolid of an >98% enantomeric purity in a solvent at >80 degrees; separating a crystal (II) of >99% purity; analysis by the powder X-ray diffraction spectrum/infrared spectrum as a mineral oil mull; bactericides; stability
12/13/2001CA2410409A1 Antitumoral compounds
12/13/2001CA2407164A1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists
12/12/2001EP1161422A1 Amine derivatives as protease inhibitors
12/12/2001EP1161416A1 Alpha-aminoacetic acid derivatives useful as alpha 4 beta 7 - receptor antagonists
12/12/2001EP0781126B1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system
12/12/2001EP0778827B1 Process for producing a beta-amino alcohol
12/12/2001EP0748319B1 Process for making an epoxide
12/11/2001US6329536 Reacting unsaturated nitroolefin compound with beta-dicarbonyl compound in the presence of a catalyst complex and a base, catalyst complex comprising a ligand and a metal complex
12/11/2001US6329409 Amine derivatives and skin preparations for external use containing the same
12/11/2001US6329408 Hypocholesterolemic agents; optically pure
12/11/2001US6329404 Pharmaceutical composition
12/11/2001US6329369 Methods of treating pain and other conditions
12/11/2001US6329143 Providing a substrate having surface bearing multiple copies of a protective group removable on exposure to an electric field or electric current; applying electric field or current to substrate; exposing to protected monomer, repeating
12/06/2001WO2001092239A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists
12/06/2001WO2001092238A1 Amorphous oxazole coumpound and its use as cox-2 inhibitor
12/06/2001WO2001092237A1 Oxaline esterquats and their use as softeners and bactericides
12/06/2001US20010049445 Process for the preparation of thiazolidinedione derivatives
12/06/2001DE10026565A1 Ionische Flüssigkeiten Ionic Liquids
12/06/2001CA2409006A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists
12/05/2001EP1160249A2 Ionic liquids
12/05/2001EP1160247A1 6,5-Fused aromatic ring systems having enhanced phosphodiesterae IV inhibitory activity
12/05/2001EP1159273A1 Compounds useful as reversible inhibitors of cathepsin s
12/05/2001EP1159237A1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
12/05/2001EP0991793B1 Method for preparing 2-aryl or 2-heterocyclyl chiral propionic acids and their esters
12/05/2001EP0636026B1 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
12/05/2001CN1325397A 2-piperazino alkylatnino benzoazole derivatives: dopamine receptor subtype sepcific ligands
12/05/2001CN1325385A Gastrin and cholecystokinin receptor ligands
12/05/2001CN1325267A Fused-benzene derivatives useful as herbicides
12/04/2001US6326133 Cyanine dyes
12/04/2001CA2278883C Very large scale immobilized peptide synthesis
11/2001
11/30/2001CA2348966A1 Ionic liquids
11/29/2001WO2001090086A1 A polymorph of 5-(4-aminosulfonyl-3-fluorophenyl)-4-cyclohexyl-2-methyloxazole
11/29/2001WO2001090074A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a)
11/29/2001WO2000034258A3 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
11/29/2001US20010047031 Heterocyclic compounds useful as NMDA receptor selective subtype blockers
11/29/2001US20010047004 Oxazolidinone thioamides with piperazine amide substituents
11/29/2001US20010046987 Potent activity against Grampositive and Gramnegative bacteria
11/29/2001CA2408727A1 Benzophenones as inhibitors of il-1.beta. and tnf-.alpha.
11/28/2001EP1156798A1 Felbamate derived compounds
11/28/2001EP0906268B1 Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors
11/28/2001EP0770068B1 Conformationally rigid bicyclic and adamantane derivatives useful as alpha 2-adrenergic blocking agents
11/28/2001EP0712394B1 Arthropodicidal oxazolines and thiazolines
11/28/2001EP0623119B1 Novel 3-halo-5-halomethyl-2-oxazolidinones and their use as microbicides
11/28/2001CN1324351A Method for the preparation of citalopram
11/28/2001CN1324005A Silver halide photographic emulsion contg. methylidyne compound, and photographic material using said emulsion
11/28/2001CN1323790A CO2 and propiolic reaction process of preparing 5-methylene-2-oxazolidone compounds
11/28/2001CN1075490C O-benzyl oxime ether derivatives and their use in crop production compositions
11/27/2001US6323229 Compounds are useful psychotherapeutics and are potent agonists and/or antagonists of the serotonin 1a (5-ht 1a) and/or serotonin 1d (5-ht 1d) for treatment of hypertension, depression, generalized anxiety disorder
11/27/2001US6323225 Pharmaceutical composition
11/27/2001US6323200 The compounds are immunomodulators and induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor, and inhibit the t-helper-type 2 immune response.
11/27/2001CA2041835C Cyclohexenone oxime ethers, their preparation and their use as herbicides
11/22/2001WO2001087859A1 Naphthol derivatives
11/22/2001WO2001087858A1 Methods for crystallization of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine n-carboxyanhydride
11/22/2001WO2001087857A1 Phenyloxazole compounds and fungicides for agricultural and horticultural use
11/22/2001WO2001087838A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001WO2001087837A1 Process and intermediates for the preparation of 1-(9h-carbazol-4-yloxy)-3-[2-(2-methoxy-phenoxy)-ethylamino]-propan-2-ol, carvedilol or acid addition salts thereof
11/22/2001WO2001087830A2 Substituted thioacetamides
11/22/2001WO2001087828A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
11/22/2001US20010044546 Prepared from chiral amino alcohols; suitable for assymetric catalysis; for transfer hydrogenation of ketones and imines; enantiomorphs; purity; efficiency
11/22/2001CA2409116A1 Substituted thioacetamides
11/22/2001CA2408849A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001CA2407103A1 Process and intermediates for the preparation of 1-(9h-carbazol-4-yloxy)-3-[2-(2-methoxy-phenoxy)-ethylamino]-propan-2-ol, carvedilol or acid addition salts thereof
11/21/2001EP1156049A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
11/21/2001EP1156043A2 Drugs that enhance synaptic responses mediated by ampa receptors
11/21/2001EP1155005A1 The preparation of chiral cis-5-amino-2-cyclopenten-1-ol derivatives
11/21/2001EP0892792B1 Process to prepare oxazolidinones
11/21/2001CN1322526A Compound for treating female sexual dysfunction
11/21/2001CN1075058C Process for producing aromatic sulfonyl halides
11/21/2001CN1075055C Process for reducing amino acids and derivatives thereof
11/20/2001US6320055 Process for preparing hydantoins or cyclic anhydrides of an amino acid
11/20/2001US6320050 2-substituted phenyl-3-cycloalkyl substituted n-heteroaromatic propionamides; used to increase insulin secretion in the treatment of type ii diabetes.
11/20/2001US6319935 Used in treatment of elevated intraocular pressure, non insulin-dependent diabetes, male impotence and obesity
11/20/2001US6319925 O-benzyl oxime ether derivatives and their use in crop protection compositions
11/20/2001US6319916 Heterocyclic compounds, their production and use
11/15/2001WO2001085725A1 Piperazine and piperidine compounds
11/15/2001WO2001085149A2 Felbamate derived compounds
11/15/2001US20010041814 Phthalic acid diamide derivatives fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
11/15/2001US20010041812 Cyclization using acyl halogenide; chemical intermediate
11/15/2001US20010041782 Novel latent curing agent and moisture-curable epoxy resin composition
11/15/2001US20010041728 With thiourea, thioamide, or dithiocarbamate functionality; (S)-N-(((3-(3-fluoro-4-morpholinyl)phenyl)-2-oxo-5 -oxazolidinyl)methyl)thioacetamide for example; treats multiple-resistant staphylococci
11/15/2001US20010041726 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/15/2001CA2407697A1 Felbamate derived compounds
11/14/2001EP1153923A1 Process for the preparation of N-Carboxy-t-Leucine anhydride
11/14/2001EP1153018A1 Process for the preparation of 4,4'-bis(2-benzoxazolyl)stilbenes
11/14/2001EP1153017A1 Bicyclic compounds and their use as integrin receptor ligands
11/14/2001EP0801700B1 Use of optically brightened plastics for optically brightening paper-coating compounds and paper-coating compounds optically brightened in this manner
11/14/2001CN1322204A Oxazolidinone antibacterial agents having thiocarbonyl functionality
11/14/2001CN1322195A Substituted pyrroldinone, thizolidinone or oxazolidinone as herbicides
11/14/2001CN1321639A Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg them
11/14/2001CN1321634A Substd heterocyclic compounds preparing method thereof and pharmaceutical composition contg. them
11/14/2001CN1074766C Alkylaminobenzothiazole and -benzoxazole derivatives